Neptune Technologies & Bioresources Inc ROE 2009-2018 | NEPT

Current and historical return on equity (ROE) values for Neptune Technologies & Bioresources Inc (NEPT) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Neptune Technologies & Bioresources Inc ROE for the three months ending December 31, 2018 was -18.85%.
Neptune Technologies & Bioresources Inc ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-12-31 $0.00B $0.06B 0.00%
2018-09-30 $0.00B $0.07B 3.49%
2018-06-30 $0.00B $0.06B 3.77%
2016-11-30 $0.01B $0.05B 10.00%
2016-08-31 $-0.00B $0.05B -8.22%
2016-05-31 $-0.00B $0.05B -8.16%
2016-03-31 $-0.00B $0.05B -5.30%
2016-02-29 $-0.01B $0.00B -15.38%
2015-12-31 $-0.01B $0.05B -23.53%
2015-09-30 $-0.01B $0.05B -21.05%
2015-06-30 $-0.02B $0.06B -33.95%
2015-03-31 $-0.02B $0.07B -30.56%
2014-12-31 $-0.02B $0.07B -21.48%
2014-09-30 $-0.02B $0.08B -33.95%
2014-06-30 $-0.02B $0.09B -24.29%
2014-03-31 $-0.02B $0.06B -28.17%
2013-12-31 $-0.02B $0.05B -28.85%
2013-09-30 $-0.01B $0.05B -17.39%
2013-06-30 $-0.02B $0.05B -38.55%
2013-03-31 $-0.02B $0.06B -43.84%
2013-02-28 $-0.02B $0.00B -55.74%
2012-12-31 $-0.02B $0.06B -43.87%
2012-09-30 $-0.01B $0.03B -15.63%
2012-06-30 $-0.00B $0.03B -9.84%
2012-03-31 $-0.00B $0.03B -10.62%
2011-12-31 $-0.00B $0.03B -4.26%
2011-09-30 $0.00B $0.03B 5.06%
2011-06-30 $0.00B $0.02B 19.05%
2011-03-31 $0.00B $0.01B 32.65%
2010-12-31 $0.00B $0.02B 19.05%
2010-09-30 $0.00B $0.01B 23.53%
2010-06-30 $0.00B $0.01B 13.79%
2010-03-31 $0.00B $0.01B 0.00%
2009-12-31 $0.00B $0.01B 0.00%
2009-09-30 $-0.00B $0.01B -63.16%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.257B $0.022B
Neptune Wellness Solutions Inc. operates as a nutrition supplement company. It develops and produces cannabis products, marine oils, seed oils and pet supplements. Neptune Wellness Solutions Inc., formerly known as Neptune Technologies & Bioressources Inc., is headquartered in Laval, Canada.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $140.623B 27.80
Medtronic (MDT) Ireland $123.520B 18.06
Stryker (SYK) United States $73.875B 27.09
Boston Scientific (BSX) United States $52.874B 25.78
Baxter (BAX) United States $40.209B 25.72
Zimmer Biomet Holdings (ZBH) United States $26.486B 16.96
Smith & Nephew SNATS (SNN) United Kingdom $17.634B 0.00
Canopy Growth (CGC) Canada $15.407B 0.00
ResMed (RMD) United States $14.469B 27.44
Aurora Cannabis (ACB) Canada $9.687B 68.36
Bio-Rad Laboratories (BIO) United States $9.455B 53.94
Hill-Rom Holdings (HRC) United States $7.140B 22.08
Perrigo (PRGO) Ireland $6.601B 10.70
Insulet (PODD) United States $6.039B 2037.40
GW Pharmaceuticals (GWPH) United Kingdom $5.309B 0.00
ICU Medical (ICUI) United States $4.841B 30.14
Haemonetics (HAE) United States $4.496B 39.88
Hutchison China MediTech (HCM) China $3.961B 0.00
Agios Pharmaceuticals (AGIO) United States $3.830B 0.00
Neogen (NEOG) United States $3.332B 51.18
NuVasive (NUVA) United States $2.927B 25.53
Quidel (QDEL) United States $2.672B 24.11
Aphria (APHA) $2.518B 111.78
National Vision Holdings (EYE) United States $2.327B 45.77
HEXO (HEXO) $1.429B 0.00
Cardiovascular Systems (CSII) United States $1.402B 1006.25
Phibro Animal Health (PAHC) United States $1.308B 18.80
VAREX IMAGING (VREX) United States $1.299B 25.44
AtriCure (ATRC) United States $1.104B 0.00
Lantheus Holdings (LNTH) United States $0.968B 26.15
MacroGenics (MGNX) United States $0.967B 0.00
Cerus (CERS) United States $0.885B 0.00
PetIQ (PETQ) United States $0.872B 24.96
Omeros (OMER) United States $0.868B 0.00
NanoString Technologies (NSTG) United States $0.753B 0.00
Meridian Bioscience (VIVO) United States $0.727B 21.67
OraSure Technologies (OSUR) United States $0.713B 31.24
Eagle Pharmaceuticals (EGRX) United States $0.705B 23.99
Evolus (EOLS) United States $0.701B 0.00
TG Therapeutics (TGTX) United States $0.650B 0.00
Surmodics (SRDX) United States $0.618B 89.94
LeMaitre Vascular (LMAT) United States $0.614B 29.21
Quanterix (QTRX) United States $0.551B 0.00
BioLife Solutions (BLFS) United States $0.397B 163.54
Vapotherm (VAPO) United States $0.371B 0.00
Rockwell Medical (RMTI) United States $0.363B 0.00
Insys Therapeutics (INSY) United States $0.358B 0.00
Utah Medical Products (UTMD) United States $0.312B 20.30
Owens & Minor (OMI) United States $0.284B 3.94
Bovie Medical (APYX) United States $0.264B 0.00
Cytosorbents (CTSO) United States $0.255B 0.00
Zynex (ZYXI) United States $0.143B 15.35
Fonar (FONR) United States $0.143B 7.64
Surface Oncology (SURF) United States $0.117B 0.00
Chimerix (CMRX) United States $0.102B 0.00
Female Health (VERU) United States $0.100B 0.00
Chembio Diagnostics (CEMI) United States $0.097B 0.00
InfuSystems Holdings (INFU) United States $0.090B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.088B 0.00
United-Guardian (UG) United States $0.087B 20.01
CAS Medical Systems (CASM) United States $0.071B 0.00
Trinity Biotech (TRIB) Ireland $0.071B 21.00
Neurotrope (NTRP) United States $0.061B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Valeritas Holdings (VLRX) United States $0.036B 0.00
Senestech (SNES) United States $0.028B 0.00
Myomo (MYO) United States $0.022B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.015B 0.00
Akers Biosciences Inc (AKER) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
NeuroMetrix (NURO) United States $0.009B 15.57